Clinical evidence for ibogaine in addiction treatment—primarily from observational studies outside the U.S.—suggests improvements in withdrawal, cravings, and mental health. However, the data is limited by lack of controlled trials, inconsistent protocols, and reliance on self-reported outcomes, raising important questions about reliability, safety, and long-term effectiveness.

Ibogaine treatment is a non-conventional intervention involving a psychoactive compound from the Tabernanthe iboga plant, producing a 24–72 hour intense physiological and psychological experience. Patients often report profound introspection and emotional insight, but the process carries significant risks, including cardiovascular and psychological concerns. Understanding the full patient experience is essential when evaluating both its therapeutic potential and safety.

Ibogaine is gaining attention as a potential treatment for addiction, particularly opioid dependence, often described as a “reset” for the brain. However, despite growing interest, it remains poorly understood, unapproved in the United States, and primarily used in international settings. Understanding its history, pharmacology, and current applications is essential to evaluating its role in modern addiction treatment.

A growing number of clinics are using black market peptides—and most patients have no idea. These unregulated products may contain contaminants, incorrect dosages, or even no active ingredient at all. Learn how to identify unsafe practices, protect yourself, and choose a clinic that prioritizes safety and transparency.

GLP-1 medications like semaglutide and tirzepatide can be powerful tools for weight loss and metabolic health—but the surge in demand has created a “Wild West” of unvetted products, online clinics, and compounded formulas. Patients must understand the risks of counterfeit drugs, improper dosing, and lack of medical oversight before starting therapy.

Retatrutide has drawn attention for promising early results in weight-loss and metabolic research. However, it is a research-grade, non-FDA-approved compound and is not intended for routine clinical use. Products marketed outside of clinical trials may carry safety, quality, and regulatory risks. Patients should understand the difference between investigational compounds and approved therapies when considering treatment options.

Prefilled semaglutide syringes may seem convenient, but they can expose patients to dosing errors, contamination risks, and unsafe practices. Here’s what you should know.

This article explains the dangers of using unregulated or bootlegged semaglutide for weight loss, including safety risks, dosing concerns, and why physician-supervised treatment matters.